OR WAIT null SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Stakeholders work to meet deadlines, maximize benefits, and close gaps.
Controlling conditions and preventing contamination are crucial for cell growth.
December 09, 2021
The additions to Crown Bioscience’s UK facility will increase and expand the company’s current in-vivo offering.
December 03, 2021
Fujifilm’s center adds local support in Suzhou, China for cell culture media optimization.
Moderna’s agreement with the UK government includes 29 million COVID-19 vaccine doses for delivery in 2022 and 31 million doses for delivery in 2023.
High price tags threaten to block patient access to potentially life-saving cures and treatments.
Bio/pharmaceutical manufacturing harnesses the benefits of digital transformation.
Polpharma implemented digital technologies, including a digital twin of operations.
Isolators move into smaller-volume processes, including cell and gene therapy manufacturing.
Simple, inexpensive real-time analytics are urgently needed for high value products.
December 02, 2021
Particle analysis is a critical component of pharmaceutical development, providing assurances of the quality and performance of the final dosage form.
Lean delivery offers a promising solution to supply and manufacturing bottlenecks by integrating project teams early on and widening the team’s field of view.